$3.3 Million raised in late November 2019, FDA fast track designation given, toxicology and pre-human results excellent, floated at 20 cents June 2017, Top 20 hold around 75%, only 500 million shares on issue, received $2 million research grant last year, Scientific Advisory Board excellent.